UCSF scientist rolls out a new blueprint for programming T cells, the 2.0 way
While analysts debate about whether or not the FDA will be willing to hand out the first CAR-T approval to Kite, the scientists in this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
